TapewireFind a company

person · Reporting owner

FLORES JESSICA

Disclosed activity across 1 company

Tapewire entity
910
SEC CIK
0002003768

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Sabra Health Care REIT, Inc.SBRA · Entity 886Executive VP & CAOAugust 31, 2026September 02, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Sabra Health Care REIT, Inc.

Report date August 31, 2026 · Filed September 02, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect72,476 Reported balance After 2026-08-31 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-08-31 · Grant · Acquired 382 · Balance 72,476

F1: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2: Includes 26,294 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Filing footnotes · ownership attribution and instrument terms

F1: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2: Includes 26,294 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 31, 2026 Filed Sep 2, 2026 21:33 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 382 $0.00 $0.00
Disclosure

SEC source: 0002003768-26-000018 · wk-form4_1788384797.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,476

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 26,294 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
May 29, 2026 Filed Jun 2, 2026 19:13 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 385 $0.00 $0.00
Disclosure

SEC source: 0002003768-26-000014 · wk-form4_1780427594.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,094

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 25,912 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
March 25, 2026 Filed Mar 27, 2026 01:25 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 SaleCommon Stock 15,231 $19.86 $302,487.66
Disclosure

SEC source: 0002003768-26-000012 · wk-form4_1774574755.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,709

F1 · price: The price report in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.85 to $19.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 25,527 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
February 27, 2026 Filed Mar 3, 2026 19:24 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 368 $0.00 $0.00
Disclosure

SEC source: 0002003768-26-000009 · wk-form4_1772565841.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,940

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 25,527 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
February 10, 2026 Filed Feb 13, 2026 01:28 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 1,172 $19.15 $22,443.80
Disclosure

SEC source: 0002003768-26-000007 · wk-form4_1770946134.xml · nonDerivative · entry 2

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,572

F2 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of restricted stock units previously granted to the reporting person.

F3 · balance_after: Includes 25,159 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
February 10, 2026 Filed Feb 13, 2026 01:28 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 3,198 $0.00 $0.00
Disclosure

SEC source: 0002003768-26-000007 · wk-form4_1770946134.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,744

F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a funds from operations-based stock unit ("FFO units") award granted on December 27, 2022, including 672 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on February 10, 2026 that the number of FFO units earned was 90.8% of the target. Upon this determination, the FFO units vested and were settled immediately. Each FFO unit represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of a funds from operations target for a performance period beginning January 1, 2025 and ending December 31, 2025.

Read SEC document
January 08, 2026 Filed Jan 13, 2026 00:10 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 3,929 $19.61 $77,047.69
Disclosure

SEC source: 0002003768-26-000004 · wk-form4_1768263018.xml · nonDerivative · entry 3

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,546

F3 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of previously vested restricted stock units previously granted to the reporting person

F4 · balance_after: Includes 25,159 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock

Read SEC document
January 08, 2026 Filed Jan 13, 2026 00:10 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 3,128 $19.61 $61,340.08
Disclosure

SEC source: 0002003768-26-000004 · wk-form4_1768263018.xml · nonDerivative · entry 2

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,475

F2 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person.

Read SEC document
January 08, 2026 Filed Jan 13, 2026 00:10 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 7,996 $0.00 $0.00
Disclosure

SEC source: 0002003768-26-000004 · wk-form4_1768263018.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,603

F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to relative total stockholder return-based stock unit ("TSR units") awards granted on December 27, 2022, including 1,680 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on January 8, 2026 that the number of TSR units earned was 200% of the target, based on the percentile ranking of the Issuer's total stockholder return among the total stockholder returns for the stocks comprising a group of preselected peer companies over the three-year performance period. Upon this determination, the TSR units vested and were settled immediately.

Read SEC document
December 31, 2025 Filed Jan 6, 2026 00:58 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 9,958 $0.00 $0.00
Disclosure

SEC source: 0002003768-26-000002 · wk-form4_1767661092.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,607

F1 · shares: Grant of stock units under the Issuer's 2009 Performance Incentive Plan. The units vest at the rate of 25% on each of December 31, 2026, December 31, 2027, December 31, 2028 and December 31, 2029. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock in the 2030 calendar year, subject to earlier payment in the event of separation from service, death, disability or change of control.

F2 · balance_after: Includes 34,030 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
November 28, 2025 Filed Dec 2, 2025 20:23 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 363 $0.00 $0.00
Disclosure

SEC source: 0002003768-25-000010 · wk-form4_1764706981.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,649

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 24,072 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
August 29, 2025 Filed Sep 3, 2025 18:10 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 367 $0.00 $0.00
Disclosure

SEC source: 0002003768-25-000008 · wk-form4_1756923008.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,286

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 23,709 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:21 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 394 $0.00 $0.00
Disclosure

SEC source: 0001976617-25-000062 · wk-form4_1748982053.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,919

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 23,342 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 19:46 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 407 $0.00 $0.00
Disclosure

SEC source: 0001976617-25-000033 · wk-form4_1741117557.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,525

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 22,948 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 20:57 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 4,085 $17.00 $69,445.00
Disclosure

SEC source: 0001976617-25-000016 · wk-form4_1737147446.xml · nonDerivative · entry 2

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,118

F2 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person.

F3 · balance_after: Includes 22,541 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 20:57 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 10,048 $0.00 $0.00
Disclosure

SEC source: 0001976617-25-000016 · wk-form4_1737147446.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,203

F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to relative total stockholder return-based stock unit ("TSR units") awards granted on December 28, 2021 and February 9, 2022, collectively, including 2,270 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on January 15, 2025 that the number of TSR units earned was 200% of the target, based on the percentile ranking of the Issuer's total stockholder return among the total stockholder returns for the stocks comprising a group of preselected peer companies over the three-year performance period. Upon this determination, the TSR units vested and were settled immediately.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 20:18 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 2,956 $17.18 $50,784.08
Disclosure

SEC source: 0001976617-25-000008 · wk-form4_1736540331.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,155

F1 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of previously vested restricted stock units previously granted to the reporting person.

F2 · balance_after: Includes 22,541 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
December 27, 2024 Filed Dec 31, 2024 19:15 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 8,813 $0.00 $0.00
Disclosure

SEC source: 0001976617-24-000093 · wk-form4_1735672505.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,111

F1 · shares: Grant of stock units under the Issuer's 2009 Performance Incentive Plan. The units vest at the rate of 25% on each of December 31, 2025, December 31, 2026, December 31, 2027 and December 31, 2028. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

F2 · balance_after: Includes 29,216 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
November 29, 2024 Filed Dec 3, 2024 22:32 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 321 $0.00 $0.00
Disclosure

SEC source: 0001862128-24-000041 · wk-form4_1733265163.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,298

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 20,403 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
August 30, 2024 Filed Sep 5, 2024 00:52 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 348 $0.00 $0.00
Disclosure

SEC source: 0001976617-24-000076 · wk-form4_1725497473.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,977

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 20,082 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 22:41 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 397 $0.00 $0.00
Disclosure

SEC source: 0001976617-24-000040 · wk-form4_1717540878.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,629

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 19,734 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 18:35 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 2,291 $13.99 $32,051.09
Disclosure

SEC source: 0001862128-24-000015 · wk-form4_1709577348.xml · nonDerivative · entry 3

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,232

F3 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

F4 · balance_after: Includes 19,337 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 18:35 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 5,976 $0.00 $0.00
Disclosure

SEC source: 0001862128-24-000015 · wk-form4_1709577348.xml · nonDerivative · entry 2

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,523

F2 · shares: Represents shares of the Issuer's Common Stock issued under the Issuer's 2009 Performance Incentive Plan subject to an annual bonus performance stock unit ("PSU") award granted on June 13, 2023, including 328 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on March 1, 2024 that the number of PSUs earned was 200.0% of the target. Upon this determination, the PSUs vested and were paid out immediately. Each PSU represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of an adjusted normalized funds from operations per share target for a performance period beginning January 1, 2023 and ending December 31, 2023.

Read SEC document
February 29, 2024 Filed Mar 4, 2024 18:35 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 409 $0.00 $0.00
Disclosure

SEC source: 0001862128-24-000015 · wk-form4_1709577348.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,547

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:27 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 1,382 $13.34 $18,435.88
Disclosure

SEC source: 0001976617-24-000025 · wk-form4_1706909255.xml · nonDerivative · entry 2

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,138

F2 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person.

F3 · balance_after: Includes 18,928 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:27 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 3,266 $0.00 $0.00
Disclosure

SEC source: 0001976617-24-000025 · wk-form4_1706909255.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,520

F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a relative total stockholder return-based stock unit ("TSR units") award granted on December 24, 2020, including 740 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on January 31, 2024 that the number of TSR units earned was 148.84% of the target, based on the percentile ranking of the Issuer's total stockholder return among the total stockholder returns for the stocks comprising a group of pre-selected peer companies over the three-year performance period. Upon this determination, the TSR units vested and were settled immediately.

Read SEC document
January 05, 2024 Filed Jan 9, 2024 21:07 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 1,359 $13.64 $18,536.76
Disclosure

SEC source: 0001976617-24-000017 · wk-form4_1704834456.xml · nonDerivative · entry 1

FLORES JESSICA · CIK 0002003768 · Executive VP & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,254

F1 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of previously vested restricted stock units previously granted to the reporting person.

F2 · balance_after: Includes 18,928 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.